Boston, Massachusetts, United States
David Sinclair, Tristan Edwards
2017
Private company
Seed
0.6
Life Biosciences
small molecule drugs
Pre-clinical
We are a global, pre-commercialization, bio-pharmaceutical company. We seek to identify compounds and targets to develop therapeutics and supplements for pets, primarily dogs, cats and horses.
Our team is a passionate group of animal health experts working with the latest in biotechnology offerings to enhance the welfare of companion animals.
As part of the Life Biosciences family of companies, we conduct research and focus on developing solutions into aging and age-related diseases. Our goal is to bring treatments to market in order to improve the quality and healthspan of animal life.